蔥白提取物聯(lián)合針刺療法治療非酒精性脂肪性肝病(痰瘀互結(jié)型)的臨床觀察
[Abstract]:Objective:
To observe the effect of the treatment of nonalcoholic fatty liver disease (phlegm and blood stasis type) by the combination of scallion extract and acupuncture therapy, and to evaluate the clinical effect of internal and external combination therapy in the treatment of nonalcoholic fatty liver disease.
Method:
From March 2012 to August 2012, 65 cases of NAFLD phlegm and blood stasis syndrome in the outpatient of a hospital in a hospital in Wuhan, the external treatment center of the spleen and the stomach, the hospitalized ward and the hospital check-up center, were randomly divided into two groups, including 33 cases (treatment group) and polyene phosphatidyl group in the group of scallion extract combined with acupuncture treatment group. 32 cases (control group) were treated with choline control group. On the basis of the intervention of behavior and lifestyle, diet adjustment and exercise, the control group was given Polyene Phosphatidylcholine Capsules (Yi Shanfu) every time 456mg oral, three times a day. The treatment group was given the onion extract (Bo Xin Tong soft capsule) for oral 800mg (2 grains) each time, two times a day. The first group: Fenglong, Zusanli, Sanyinjiao, Zhong Wan, Yang Ling spring, Zhang gate in the first group: second groups: phrenic Shu, Shan Zhong, Lianshu, Tai Chung, Hegu; each select a group of acupoints, the needle after the gas is 30min, 1 times the needle, medium intensity stimulation; once a day, the same group of acupuncture points for 6 days, rest. 1 days after another group of acupoints, the two groups were treated with 12 weeks as a course of treatment. After the end of the course, the two groups of curative effects were observed, including the symptom score of the Chinese medicine before and after the treatment, the score score of ultrasonic examination, the index of human body (height, weight, waist circumference, BMI), the liver function (ALT, AST, GGT), the blood lipid (TC, TG, HDL-C, LDL-C), arterial blood pressure and fasting blood glucose, and the arterial blood pressure and fasting blood glucose. Statistical analysis.
SPSS19.0 software was used for data management and statistical analysis. The results were both bilateral and P < 0.05, with P < 0.01 as the standard of very significant difference. The measurement data were expressed in X + S, if the normal distribution (Fang Chaqi) was subordinate to the normal distribution (Fang Chaqi), the paired comparison t test was used in the group, and two samples were compared with the t test among the groups. Rank sum test was used if normal distribution was not obeyed.Rank sum test was used for grade data and_2test was used for count data.
Result:
1. according to the overall evaluation standard of curative effect, the total effective rate of the treatment group was 84.85%, the total effective rate of the control group was 78.13%. The total curative effect of the two groups was significantly different (P < 0.05), and the total effective rate of the control group was significantly different (P < 0.05).
It has statistical significance.
2. there was no significant difference in the anthropometric indexes (weight, waist circumference and BMI) and blood pressure before and after treatment in the two groups (P > 0.05). The other indexes in the two groups were significantly different from those before treatment (P < 0.05 or P < 0.01). The two groups were compared with the treatment group, including ALT, AST, and TG in the treatment group, and there was no comparison between the control group and the control group. The difference was significant (P > 0.05), while the TC, HDL-C and LDL-C in the treatment group were significantly different from those in the control group (P < 0.05), and there was a significant difference between the control group and the treatment group (P < 0.05).
3. according to the evaluation criteria of ultrasonic examination scores, there were significant differences between the two groups after treatment (P < 0.05), but there was no significant difference between the two groups after treatment (P > 0.05).
4. according to the evaluation standard of TCM symptom score, there was significant difference between the two groups after treatment (P < 0.01 in the treatment group and P < 0.05 in the control group), and there was significant difference between the treatment group and the control group after treatment (P < 0.05).
Conclusion:
This study shows that two treatment methods have some therapeutic effect on NAFLD patients, but the treatment group is obviously superior to the control group in improving the clinical symptoms and TC, HDL-C and LDL-C. The control group has some advantages in improving the patient's GGT and other aspects, and the curative effect is equivalent in the other sides of the other sides of the ultrasound imaging and other sides; fully display the use of "Tong Yang". In theory, the combination of scallion extract and acupuncture therapy in the treatment of NAFLD (phlegm and blood stasis type) has some advantages in improving the patient's symptoms and improving the quality of life. It is worth further research and promotion.
【學(xué)位授予單位】:湖北中醫(yī)藥大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2013
【分類號】:R259;R246.1
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 王京齊;張景;薛鳳敏;王海峰;;四生降脂方治療非酒精性脂肪肝64例臨床觀察[J];北京中醫(yī)藥;2008年03期
2 鄭瓊莉,張介眉,喻榮輝,賀立群,柯于鶴;射心通膠囊治療冠心病心絞痛臨床研究[J];中國醫(yī)藥學(xué)報(bào);2003年03期
3 蘇經(jīng)格;四君子湯加味治療非酒精性脂肪肝臨床觀察[J];中國醫(yī)藥學(xué)報(bào);2004年08期
4 時昭紅;張介眉;林麗莉;劉浩;郭潔;;蔥白提取物對脂肪變性肝細(xì)胞模型PPAR-α及PGC-1表達(dá)的影響[J];中華中醫(yī)藥雜志;2011年09期
5 戶菲菲;張介眉;朱旭;鄭亞瓊;吳云霞;郝建軍;崔清國;;通陽藥蔥白提取物對肝竇毛細(xì)血管化大鼠肝組織MMP-2,TIMP-2蛋白及mRNA表達(dá)影響的研究[J];成都中醫(yī)藥大學(xué)學(xué)報(bào);2010年04期
6 曾民德;脂肪性肝病的氧應(yīng)激及其治療對策[J];國外醫(yī)學(xué)(消化系疾病分冊);2005年05期
7 林剛;鐘妍;范建高;;2型糖尿病對非酒精性脂肪性肝病的影響[J];國際消化病雜志;2008年06期
8 李娟;葉菲;;非酒精性脂肪性肝病發(fā)病機(jī)制的研究進(jìn)展[J];國際藥學(xué)研究雜志;2011年05期
9 曾明曦;王一平;伍麗萍;;抗氧化劑治療非酒精性脂肪性肝病的系統(tǒng)評價[J];南方醫(yī)科大學(xué)學(xué)報(bào);2012年05期
10 王竟吉,李娜,杜天銀;杜氏防止“穴位疲勞”經(jīng)驗(yàn)四法[J];甘肅中醫(yī);2005年10期
相關(guān)碩士學(xué)位論文 前2條
1 林麗莉;鮮蔥白提取物對非酒精性脂肪肝TNF-α影響的臨床和實(shí)驗(yàn)研究[D];湖北中醫(yī)藥大學(xué);2010年
2 韋秀明;鮮蔥白提取物對非酒精性脂肪肝血液流變學(xué)影響的臨床和實(shí)驗(yàn)研究[D];湖北中醫(yī)藥大學(xué);2010年
本文編號:2167697
本文鏈接:http://sikaile.net/yixuelunwen/zhxiyjh/2167697.html